Developer docs
API playgroundTry for free, no card

Search company profiles

Ninapharm

Full company profile

uuid00sjydf

Namestring
Ninapharm
Websiteurl
ninapharm.com
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Ninapharm is a France-based biotechnology company headquartered in Annecy, founded in 1993 and operating with a headcount in the 51-100 range. The company is positioned around a single integrated technology platform that combines microbiome science with mitochondria-targeted energy interventions, framed by the company as a longevity offering intended to support healthy aging and extended human lifespan. The company presents its offering through a corporate website with trilingual content (English, French, Japanese), a YouTube video, and a single branded product page describing the 'Microbiome + Mitochondria Longevity Technology' platform; no distinct modular products, pricing, certifications, regulatory clearances, partnerships, named customers, or pipeline assets are disclosed in the available source material.

The company's go-to-market, pricing model, and revenue mechanics are not described in the available sources. There is no disclosure of distribution channels, customer segments, sales motion, or commercial milestones, and the firmographic data does not include investors, funding rounds, M&A activity, leadership team, patents, regulatory actions, or geographic operating footprint. As a result, the available evidence supports only a limited description of the company's commercial posture: it appears to operate as a small, privately held French biotech with a narrow, longevity-themed technical focus and minimal public commercial disclosure.

Short descriptiontext

Ninapharm is a France-based private biotechnology company developing a combined microbiome and mitochondria energy technology platform aimed at supporting human longevity and healthy aging.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAnnecy, France
HQ citystring
Annecy
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
mitochondrial energy technology, microbiome health products, longevity biotechnology, cellular energy science, healthy aging solutions
Industry1 code
PRIMARYHSADAGAK
Healthy Aging & Longevity Lifestyle Coaching
Product category
Longevity Biotechnology
Social media profiles2 records
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Ninapharm develops and provides a longevity technology platform that combines advanced Microbiome and Mitochondria energy technologies aimed at supporting healthy human aging and extending healthy lifespan. The offering is positioned as a unified science-based approach to cellular energy and gut microbiome health, with the stated consumer outcome of gracefully living to 100 years.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ninapharm is a longevity-focused pharmaceutical/biotechnology company pioneering human longevity through advanced Microbiome and Mitochondria energy technologies. Their core offering centers on a unified technology platform aimed at helping individuals gracefully live to 100 years. No distinct modular products, add-ons, or separate product lines are explicitly named in the available source material.

Product and service1 record
1Microbiome + Mitochondria Longevity Technology
CategoryLongevity biotechnology platform
Description

Advanced longevity technology platform combining microbiome and mitochondria energy solutions designed to support healthy aging and extend human lifespan to 100 years, targeted at individual consumers interested in proactive longevity.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Consumer-facing longevity biotech selling proprietary cellular health supplements (e.g., Basis with NAD+ precursors). Closely comparable to Ninapharm as a science-branded longevity product company targeting healthy aging through cellular/mitochondrial mechanisms.

TypeDirect peer
Description

Long-established consumer longevity supplements company offering a wide catalog of anti-aging and cellular health products. Comparable to Ninapharm as a longevity-focused consumer health brand with international reach.

TypeEmerging player
Description

Personalized nutrition company built on microbiome science and metabolic testing, with consumer subscriptions for gut health programs. Comparable to Ninapharm specifically for its microbiome science foundation applied to consumer health.

TypeDirect peer
Description

Premium supplements and health testing company with strong scientific branding and partnerships (e.g., Mayo Clinic). Comparable to Ninapharm for its premium, science-led positioning in the consumer health/longevity space.

TypeEmerging player
Description

Personalized health and longevity platform combining biomarker testing with supplement and lifestyle recommendations. Comparable for the consumer-facing intersection of biotech, personalized wellness, and healthy aging.

TypeBroad incumbent
Description

Alphabet-backed longevity R&D organization with substantial funding and academic partnerships studying aging biology. Comparable as an incumbent longevity biotech working on cellular mechanisms of aging, though operating primarily in deep research rather than consumer products.

TypeBroad incumbent
Description

Well-funded longevity biotech focused on cellular rejuvenation biology, backed by multi-billion-dollar investment. Comparable as a major longevity biotech competitor with deep scientific resources, though more research-stage than Ninapharm's apparent consumer orientation.

TypeEmerging player
Description

Longevity biotech developing a pipeline of therapeutics and consumer health products targeting aging biology. Comparable as a longevity platform company operating across multiple anti-aging mechanisms.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ninapharm

Longevity Biotechnologyninapharm.com

Ninapharm is a France-based private biotechnology company developing a combined microbiome and mitochondria energy technology platform aimed at supporting human longevity and healthy aging.

What Ninapharm does

Ninapharm is a France-based biotechnology company headquartered in Annecy, founded in 1993 and operating with a headcount in the 51-100 range. The company is positioned around a single integrated technology platform that combines microbiome science with mitochondria-targeted energy interventions, framed by the company as a longevity offering intended to support healthy aging and extended human lifespan. The company presents its offering through a corporate website with trilingual content (English, French, Japanese), a YouTube video, and a single branded product page describing the 'Microbiome + Mitochondria Longevity Technology' platform; no distinct modular products, pricing, certifications, regulatory clearances, partnerships, named customers, or pipeline assets are disclosed in the available source material.

The company's go-to-market, pricing model, and revenue mechanics are not described in the available sources. There is no disclosure of distribution channels, customer segments, sales motion, or commercial milestones, and the firmographic data does not include investors, funding rounds, M&A activity, leadership team, patents, regulatory actions, or geographic operating footprint. As a result, the available evidence supports only a limited description of the company's commercial posture: it appears to operate as a small, privately held French biotech with a narrow, longevity-themed technical focus and minimal public commercial disclosure.

Ninapharm firmographics

Firmographics
Name
Ninapharm
Website
https://ninapharm.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
1–10 employees
Short description
Ninapharm is a France-based private biotechnology company developing a combined microbiome and mitochondria energy technology platform aimed at supporting human longevity and healthy aging.
Ownership category
akta.pro rank

Ninapharm industry classification

Industry
Product category
Longevity Biotechnology
akta.pro industry
PRIMARYHSADAGAK
Healthy Aging & Longevity Lifestyle Coaching

Keywords

  • Mitochondrial energy technology
  • Microbiome health products
  • Longevity biotechnology
  • Cellular energy science
  • Healthy aging solutions

Where Ninapharm is headquartered

Location

Headquarters

HQ city
Annecy
HQ country
France
HQ region
Europe

Markets served

Ninapharm business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Ninapharm product offering

Product offering

Core offering

Ninapharm develops and provides a longevity technology platform that combines advanced Microbiome and Mitochondria energy technologies aimed at supporting healthy human aging and extending healthy lifespan. The offering is positioned as a unified science-based approach to cellular energy and gut microbiome health, with the stated consumer outcome of gracefully living to 100 years.

Product overview

Ninapharm is a longevity-focused pharmaceutical/biotechnology company pioneering human longevity through advanced Microbiome and Mitochondria energy technologies. Their core offering centers on a unified technology platform aimed at helping individuals gracefully live to 100 years. No distinct modular products, add-ons, or separate product lines are explicitly named in the available source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Microbiome + Mitochondria Longevity Technology Advanced longevity technology platform combining microbiome and mitochondria energy solutions designed to support healthy aging and extend human lifespan to 100 years, targeted at individual consumers interested in proactive longevity.

Companies that use Ninapharm

Customer profile

Ideal customer profiles1 record

Ninapharm technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ninapharm partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Ninapharm competitors and assessment

Company assessment

Direct peers

  • Elysium Health: Consumer-facing longevity biotech selling proprietary cellular health supplements (e.g., Basis with NAD+ precursors). Closely comparable to Ninapharm as a science-branded longevity product company targeting healthy aging through cellular/mitochondrial mechanisms.
  • Life Extension: Long-established consumer longevity supplements company offering a wide catalog of anti-aging and cellular health products. Comparable to Ninapharm as a longevity-focused consumer health brand with international reach.
  • Thorne HealthTech: Premium supplements and health testing company with strong scientific branding and partnerships (e.g., Mayo Clinic). Comparable to Ninapharm for its premium, science-led positioning in the consumer health/longevity space.

Emerging players

  • ZOE: Personalized nutrition company built on microbiome science and metabolic testing, with consumer subscriptions for gut health programs. Comparable to Ninapharm specifically for its microbiome science foundation applied to consumer health.
  • InsideTracker: Personalized health and longevity platform combining biomarker testing with supplement and lifestyle recommendations. Comparable for the consumer-facing intersection of biotech, personalized wellness, and healthy aging.
  • Juvenescence: Longevity biotech developing a pipeline of therapeutics and consumer health products targeting aging biology. Comparable as a longevity platform company operating across multiple anti-aging mechanisms.

Broad incumbents

  • Calico Life Sciences: Alphabet-backed longevity R&D organization with substantial funding and academic partnerships studying aging biology. Comparable as an incumbent longevity biotech working on cellular mechanisms of aging, though operating primarily in deep research rather than consumer products.
  • Altos Labs: Well-funded longevity biotech focused on cellular rejuvenation biology, backed by multi-billion-dollar investment. Comparable as a major longevity biotech competitor with deep scientific resources, though more research-stage than Ninapharm's apparent consumer orientation.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks5 records

Key highlights5 records

Customer concentration

Ninapharm social profiles

Digital presence

Ninapharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ninapharm leadership team

Management profile

Number of profiles

Ninapharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ninapharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ninapharm

What does Ninapharm do?

Ninapharm develops and provides a longevity technology platform that combines advanced Microbiome and Mitochondria energy technologies aimed at supporting healthy human aging and extending healthy lifespan. The offering is positioned as a unified science-based approach to cellular energy and gut microbiome health, with the stated consumer outcome of gracefully living to 100 years.

Is Ninapharm a public or private company?

Ninapharm is a private company. It is classified as unknown and is currently operating.

When was Ninapharm founded?

Ninapharm was founded in 1993. It employs 1 to 10 people.

Where is Ninapharm based?

Ninapharm is headquartered in Annecy, France, in the Europe region.

Who are Ninapharm's main competitors?

Direct peers on record are Elysium Health, Life Extension and Thorne HealthTech. Emerging players are ZOE, InsideTracker and Juvenescence. Broad incumbents are Calico Life Sciences and Altos Labs.

Does Ninapharm have an API?

No public API is recorded for Ninapharm.

What industry is Ninapharm in?

Ninapharm's product category is Longevity Biotechnology. Its primary akta.pro industry code is HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales